Inventor · disambiguated record
George S. Sheppard
Also filed as: SHEPPARD GEORGE S · SHEPPARD George
36 granted patents·28 pending applications·650 citations·filing 1991–2024
98Inventor score
Top patents by PatentIndex Score
64 records- 0194US7772231B2Substituted pyrazolo[3,4-d]pyrimidines as protein kinase inhibitorsABBOTT LAB·Filed 2006·Granted Aug 10, 2010·68 cites·20 claims
- 0294US7030262B23-Amino-2-hydroxyalkanoic acids and their prodrugsABBOTT LAB·Filed 2003·Granted Apr 18, 2006·42 cites·4 claims
- 0393US5486525APlatelet activating factor antagonists: imidazopyridine indolesABBOTT LAB·Filed 1994·Granted Jan 23, 1996·136 cites·10 claims
- 0492US6887863B2Hydrazide and alkoxyamide angiogenesis inhibitorsABBOTT LAB·Filed 2004·Granted May 3, 2005·32 cites·40 claims
- 0592US6288228B1Triazine angiogenesis inhibitorsABBOTT LAB·Filed 2000·Granted Sep 11, 2001·37 cites·12 claims
- 0690US7491718B2Sulfonamides having antiangiogenic and anticancer activityABBOTT LAB·Filed 2003·Granted Feb 17, 2009·35 cites·3 claims
- 0788US2025152600A1Bromodomain inhibitorsABBVIE INC·Filed 2024·Application pending·0 cites
- 0887US10633379B2Bromodomain inhibitorsABBVIE INC·Filed 2017·Granted Apr 28, 2020·4 cites·2 claims
- 0987US9296741B2Bromodomain inhibitorsABBVIE INC·Filed 2013·Granted Mar 29, 2016·7 cites·61 claims
- 1087US6242494B1Substituted β-amino acid inhibitors of methionine aminopeptidase-2ABBOTT LAB·Filed 1999·Granted Jun 5, 2001·47 cites·15 claims
- 1185US5567711AIndole-3-carbonyl and indole-3-sulfonyl derivatives as platelet activating factor antagonistsABBOTT LAB·Filed 1995·Granted Oct 22, 1996·59 cites·7 claims
- 1283US5952320AMacrocyclic inhibitors of matrix metalloproteinases and TNFα secretionABBOTT LAB·Filed 1997·Granted Sep 14, 1999·34 cites·13 claims
- 1383US2024360124A1Bromodomain InhibitorsABBVIE INC·Filed 2023·Application pending·0 cites
- 1480US9050346B2Bromodomain inhibitorsABBVIE INC·Filed 2014·Granted Jun 9, 2015·5 cites·20 claims
- 1580US6849757B2Antiangiogenic drug to treat cancer, arthritis and retinopathyABBOTT LAB·Filed 2003·Granted Feb 1, 2005·9 cites·4 claims
- 1680US2023158039A1Bromodomain inhibitorsABBVIE INC·Filed 2022·Application pending·0 cites
- 1779US9957263B2Bromodomain inhibitorsABBVIE INC·Filed 2014·Granted May 1, 2018·3 cites·5 claims
- 1878US10085985B2Bromodomain inhibitorsABBVIE INC·Filed 2016·Granted Oct 2, 2018·2 cites·21 claims
- 1978US10035800B2Substituted 1,4,10-triazadibenzo[cd,f]azulenes, substituted 1,4,5,10-tetraazadibenzo[cd,f]azulenes and substituted 1,4,5,7,10-pentaazadibenzo[cd,f]azulenes as bromodomain inhibitorsABBVIE INC·Filed 2014·Granted Jul 31, 2018·3 cites·48 claims
- 2077US9561231B2Pyridinone and pyridazinone derivativesABBVIE INC·Filed 2013·Granted Feb 7, 2017·4 cites·43 claims
- 2177US9321764B2Dihydro-pyrrolopyridinone inhibitorsABBVIE INC·Filed 2014·Granted Apr 26, 2016·3 cites·25 claims
- 2277US5654305AIndole piperazine platelet activating factor antagonistsABBOTT LAB·Filed 1996·Granted Aug 5, 1997·35 cites·8 claims
- 2376US9493411B2Pyrrole-3-carboxamide bromodomain inhibitorsABBVIE INC·Filed 2014·Granted Nov 15, 2016·3 cites·12 claims
- 2475US10131657B2Bromodomain inhibitorsABBVIE INC·Filed 2014·Granted Nov 20, 2018·2 cites·14 claims
- 2575US8354422B2Pyrimidine inhibitors of kinase activityABBOTT LAB·Filed 2010·Granted Jan 15, 2013·2 cites·18 claims
- 2674US8486933B2Pyrimidine inhibitors of kinase activityWANG GARY T·Filed 2010·Granted Jul 16, 2013·3 cites·22 claims
- 2772US9428514B2Bromodomain inhibitorsABBVIE INC·Filed 2014·Granted Aug 30, 2016·1 cites·24 claims
- 2872US6632961B1Antiangiogenic drug to treat cancer, arthritis and retinopathyABBOTT LAB·Filed 1999·Granted Oct 14, 2003·12 cites·5 claims
- 2972US2021236508A1Bromodomain inhibitorsABBVIE INC·Filed 2020·Application pending·0 cites
- 3070US9776990B2Isoindolone derivativesABBVIE INC·Filed 2013·Granted Oct 3, 2017·1 cites·10 claims
- 3170US2021070756A1Tetracyclic bromodomain inhibitorsABBVIE INC·Filed 2020·Application pending·0 cites
- 3270US2022017511A1Bromodomain InhibitorsABBVIE INC·Filed 2021·Application pending·0 cites
- 3369US2021179556A1Primary carboxamides as btk inhibitorsABBVIE INC·Filed 2021·Application pending·0 cites
- 3468US2020291027A1Tetracyclic bromodomain inhibitorsABBVIE INC·Filed 2020·Application pending·0 cites
- 3567US2025000993A1Anti-human cd33 bet degrader antibody-drug conjugatesABBVIE INC·Filed 2024·Application pending·0 cites
- 3667US2020255426A1Bromodomain InhibitorsABBVIE INC·Filed 2020·Application pending·0 cites
- 3766US5665777ABiphenyl hydroxamate inhibitors of matrix metalloproteinasesABBOTT LAB·Filed 1995·Granted Sep 9, 1997·24 cites·14 claims
- 3866US2019284135A1Primary carboxamides as btk inhibitorsABBVIE INC·Filed 2019·Application pending·0 cites
- 3965US9567339B2Primary carboxamides as BTK inhibitorsABBVIE INC·Filed 2014·Granted Feb 14, 2017·0 cites·20 claims
- 4065US2018296566A1Bromodomain inhibitorsABBVIE INC·Filed 2018·Application pending·0 cites
- 4164US5985911AC-terminal ketone inhibitors of matrix metalloproteinases and TNFα secretionABBOTT LAB·Filed 1997·Granted Nov 16, 1999·10 cites·13 claims
- 4263US2019389861A1Tetracyclic bromodomain inhibitorsABBVIE INC·Filed 2019·Application pending·0 cites
- 4361US9051315B2Imidazopyridines as a novel scaffold for multi-targeted kinase inhibitionBA-MAUNG NWE Y·Filed 2010·Granted Jun 9, 2015·1 cites·4 claims
- 4461US2018298003A1Tetracyclic bromodomain inhibitorsABBVIE INC·Filed 2018·Application pending·0 cites
- 4558US2016143916A1Bromodomain inhibitorsABBVIE INC·Filed 2016·Application pending·0 cites
- 4658US2017174624A1Primary carboxamides as btk inhibitorsABBVIE INC·Filed 2017·Application pending·0 cites
- 4757US2021047304A1Bromodomain InhibitorsABBVIE INC·Filed 2020·Application pending·0 cites
- 4856US2019084981A1Bromodomain InhibitorsABBVIE INC·Filed 2018·Application pending·0 cites
- 4956US2019008866A1Bromodomain inhibitorsABBVIE INC·Filed 2018·Application pending·0 cites
- 5054US5643922AIndole cyclohexyl platelet activating factor antagonistsABBOTT LAB·Filed 1996·Granted Jul 1, 1997·9 cites·7 claims
Showing the top 50 of 64 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →